+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

China Percutaneous Coronary Interventions Landscape, Procedure and Technology Trends, Brand Perception, Competitive Intelligence and Future Outlook

  • PDF Icon

    Report

  • 158 Pages
  • January 2022
  • Region: China
  • Cetas Healthcare
  • ID: 5648194

Rotational Atherectomy Accounts for More Than 40% of the Atherectomy Prcodures Performed in China

Why Buy This Report

  • First-ever syndicated report with robust insights from Interventional Cardiologists and Cardiologists
  • Helps in understanding the current market scenario of the percutaneous coronary interventions in China
  • Includes 100+ slide MS PowerPoint report and a MS Excel based 5-year market forecast model
  • Valuable insights from from demand side of the market
  • Keep up with the latest market trends and novel technologies
  • Identify key players, local players and emerging players in the market

Table of Contents

RESEARCH PROCESS OVERVIEW
  • Detailed Research Methodology
  • Desk Research and Quantitative Research

EXECUTIVE SUMMARY

PERCUTANEOUS CORONARY INTERVENTION (PCI) CHINA MARKET OVERVIEW
  • Market Background - What is the scope of the research?

I - HEALTHCARE INFRASTRUCTURE (PROVIDER)
  • Healthcare Delivery Structure
  • Cardiac Catheterization and Chest Pain Centres (CPC) in China
  • Chest Pain Centers (CPC) - Impact on Diagnosis and Treatment
  • Healthcare Infrastructure - Digital Health Technology (DHT)
  • Healthcare Infrastructure Challenges
  • Percutaneous Coronary Intervention - Access Point

II - PROCEDURE INSIGHTS
  • Procedure Split by Facility Type
  • Procedure Split by Imaging Type
  • Procedure Split by Device Type
  • Procedure Split by Techniques
  • Procedure Split by Intervention Type
  • Procedure Growth Rates

III - BRAND PERCEPTION
  • Brand Perception (Interventionalists)
  • Best-in-Class Brands

IV - COMPETITIVE INTELLIGENCE
  • CI Snapshot
  • Key Competitor Activities
  • Product portfolio
  • Product Approval Overview
  • Clinical Trials Overview
  • Company Profile
  • Product Approvals
  • Clinical Trials
  • Partnerships, M&A, Collaborations
  • Key Market Activities
  • Major Adverse Events

V - HEALTHCARE POLICY (PAYER)
  • Medical Devices Regulatory Body
  • Regulatory Approval Pathway
  • Reimbursement landscape
  • Disease Screening and Awareness Programs
  • Health Insurance Coverage
  • Digital Health Policy

VI - CLINICAL INTELLIGENCE (PHYSICIAN)
  • Referral Pathway
  • Treatment Overview
  • Treatment Care Pathway
  • Interventional Therapies
  • Interventional Technology
  • Healthcare Specialists (who are the Performing Physicians)
  • Epidemiology

CONCLUSION
  • FUTURE TRENDS

APPENDICES

Companies Mentioned

  • Boston Scientific
  • Medtronic
  • Cordis
  • B.Braun
  • Shockwave Medical
  • Philips
  • Terumo
  • BD/Bard
  • Concept Medical
  • OrbusNeich
  • Microport Scientific
  • JW Medical
  • Genoss
  • Shanghai Bio-heart biological Technology Co
  • Elixir Medical Corporation
  • Abbott
  • Sinomed
  • Kossel MedTech
  • Biosensors International
  • Lepu Medical
  • LifeTech Scientific